Dolutegravir Safety Review: WHO Subcommittee Meeting

Europe/Zurich
In-Person
E170 (WHO, Geneva, Switzerland)

E170

WHO

Avenue Appia 20, 1202, Geneva, Switzerland
Description
Meeting of the sub-committee of the WHO Advisory Committee on Safety of Medicinal Products (ACSoMP) on the signal of neural tube defect (NTD) with dolutegravir
The agenda of this meeting is empty